Cell cycle regulation and its aberrations in human lung carcinoma (Q36060004)

11 August 2017

1 reference

title

Cell cycle regulation and its aberrations in human lung carcinoma (English)

1 reference

11 August 2017

Yoh Dobashi

1

1 reference

11 August 2017

publication date

1 March 2005

1 reference

11 August 2017

published in

Pathology International

1 reference

11 August 2017

volume

55

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

95-105

1 reference

The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Principles of CDK regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

A novel cyclin encoded by a bcl1-linked candidate oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Cyclin A expression in normal and transformed alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Induction of apoptosis in fibroblasts by c-myc protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Overexpression of cdk4/cyclin D1 induces apoptosis in PC12 cells in the presence of trophic support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Overexpression of cdk4/cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Tumor extension and cell proliferation in adenocarcinomas of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1827.2005.01799.X

10.1111/J.1440-1827.2005.01799.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference